2018 Nurse's Drug Handbook
Seiten
2017
|
17th Revised edition
Jones and Bartlett Publishers, Inc (Verlag)
978-1-284-12134-6 (ISBN)
Jones and Bartlett Publishers, Inc (Verlag)
978-1-284-12134-6 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
Jones & Bartlett Learning 2018 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically.
The 2018 Nurse’s Drug Handbook includes:
* Index of all generic, trade, and alternate drug names
* Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
* Indications and dosages, as well as route, onset, peak, and duration information
* Incompatibilities and contraindications
* Interactions with drugs, food, and activities
* Adverse reactions
* Nursing considerations, including key teaching points for patients
* Mechanism-of-action illustrations
* Warnings and precautions
New drugs include: bezlotoximab (Zinplava), brivaracetam (Briviact), daclizumab (Zinbryta), ixekizumab (Taltz), lixisenatide (Adlyxin), obiltoxaximab (Anthim), phentermine (Adipex-P), plecanatide (Trulance), prasterone (Intrarosa), and reslizumab (Cinqair).
The 2018 Nurse’s Drug Handbook includes:
* Index of all generic, trade, and alternate drug names
* Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
* Indications and dosages, as well as route, onset, peak, and duration information
* Incompatibilities and contraindications
* Interactions with drugs, food, and activities
* Adverse reactions
* Nursing considerations, including key teaching points for patients
* Mechanism-of-action illustrations
* Warnings and precautions
New drugs include: bezlotoximab (Zinplava), brivaracetam (Briviact), daclizumab (Zinbryta), ixekizumab (Taltz), lixisenatide (Adlyxin), obiltoxaximab (Anthim), phentermine (Adipex-P), plecanatide (Trulance), prasterone (Intrarosa), and reslizumab (Cinqair).
Founded in 1983, Jones & Bartlett Learning is a world-leading provider of instructional, assessment, and learning-performance management solutions for the secondary education, post-secondary education, and professional markets. We develop educational programs and services that improve learning outcomes and enhance student achievement by combining authoritative content written by respected authors with innovative, proven, and engaging technology applications that meet the diverse needs of today's instructors, students, and professionals.
| Erscheinungsdatum | 25.02.2018 |
|---|---|
| Verlagsort | Sudbury |
| Sprache | englisch |
| Gewicht | 1361 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Medizin / Pharmazie ► Pflege ► Ausbildung / Prüfung | |
| ISBN-10 | 1-284-12134-8 / 1284121348 |
| ISBN-13 | 978-1-284-12134-6 / 9781284121346 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Arzneimittelverzeichnis für Deutschland (einschließlich …
Buch | Hardcover (2024)
Rote Liste Service GmbH (Verlag)
CHF 149,95
Englisch für Apotheker und PTAs
Buch | Spiralbindung (2024)
Kohlhammer (Verlag)
CHF 44,75
